Pertactin-deficient isolates: evidence of increased circulation in Europe, 1998 to 2015.

Alex-Mikael Barkoff,Jussi Mertsola,Denis Piérard,Tine Dalby,Silje Vermedal Hoegh,Sophie Guillot,Paola Stefanelli,Marjolein van Gent,Guy A. M. Berbers,Didrik F. Vestrheim,Margrethe Greve-Isdahl,Lena Wehlin,Margaretha Ljungman,Norman K. Fry,Kevin Markey,Qiushui He

Pertactin-deficient isolates: evidence of increased circulation in Europe, 1998 to 2015.

2019

Alex-Mikael Barkoff
Jussi Mertsola
Denis Piérard
Tine Dalby
Silje Vermedal Hoegh
Sophie Guillot
Paola Stefanelli
Marjolein van Gent
Guy A. M. Berbers
Didrik F. Vestrheim
Margrethe Greve-Isdahl
Lena Wehlin
Margaretha Ljungman
Norman K. Fry
Kevin Markey
Qiushui He

IntroductionPertussis outbreaks have occurred in several industrialised countries using acellular pertussis vaccines (ACVs) since the 1990s. High prevalence of pertactin (PRN)-deficient

Keywords:

Acellular pertussis vaccines
Pertactin
Virology
Outbreak
Biology
high prevalence
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations